Literature DB >> 17713121

[Pathology of familial Parkinson's disease].

Koichi Wakabayashi1, Hitoshi Takahashi.   

Abstract

Studies of familial forms of Parkinson's disease (PD) have identified a growing number of genes that derive from the loci given the nomenclature PARK1-PARK13 (OMIM 168600). The alpha-synuclein gene has been implicated in rare autosomal dominant PD because of either mis-sense mutations (PARK1) or gene multiplications (PARK4). Moreover, UCHL1 (PARK5), LRRK2 (PARK8) and HTRA2 (PARK13) have been identified as causative genes for autosomal dominant PD, whereas parkin (PARK2), PINK1 (PARK6), DJ-1 (PARK7) and ATP13A2 (PARK9) have been identified as causative genes for autosomal recessive PD. Neuropathological examination of the kindreds of PARK1/4 showed Lewy body pathology ranging from classic PD to diffuse Lewy body disease. The pathological findings of PARK3 are similar to those of classic PD. In contrast, autopsies of patients with PARK2 showed nigral cell loss without Lewy bodies, although exceptions have been reported. Several kindreds of PARK8 included cases with Lewy body pathology, tau pathology, or with nigral cell loss in the absence of obvious protein deposition. Ubiquitin-positive inclusions that are negative for alpha-synuclein and tau are also seen in some cases. Moreover, widespread Lewy body pathology was also reported in several cases of familial Alzheimer's disease with presenilin-1 mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713121

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  5 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.

Authors:  Mali Jiang; Yair Porat-Shliom; Zhong Pei; Yong Cheng; Lan Xiang; Katherine Sommers; Qing Li; Frank Gillardon; Bastian Hengerer; Cynthia Berlinicke; Wanli W Smith; Donald J Zack; Michelle A Poirier; Christopher A Ross; Wenzhen Duan
Journal:  J Neurochem       Date:  2010-04-19       Impact factor: 5.372

3.  Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons.

Authors:  Shahrooz Vahedi; Mehrnoosh Rajabian; Arman Misaghian; Daniel Grbec; Horst H Simon; Kambiz N Alavian
Journal:  J Biomed Sci       Date:  2010-08-17       Impact factor: 8.410

4.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

5.  LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models.

Authors:  Patrícia Silva Guerreiro; Yue Huang; Amanda Gysbers; Danni Cheng; Wei Ping Gai; Tiago Fleming Outeiro; Glenda Margaret Halliday
Journal:  J Mol Med (Berl)       Date:  2012-11-27       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.